{"title":"Bioprinting","authors":"","doi":"10.1038/s41587-025-02662-4","DOIUrl":"https://doi.org/10.1038/s41587-025-02662-4","url":null,"abstract":"Recent patents relating to systems, methods and compositions for bioprinting.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"74 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144066967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anne E. Robinson, Barrie Cascella, Marta M. Wegorzewska, Daniel A. Berkovich, Joseph M. Jez
{"title":"The Biotech Explorers Pathway equips students for STEM futures","authors":"Anne E. Robinson, Barrie Cascella, Marta M. Wegorzewska, Daniel A. Berkovich, Joseph M. Jez","doi":"10.1038/s41587-025-02666-0","DOIUrl":"https://doi.org/10.1038/s41587-025-02666-0","url":null,"abstract":"Building undergraduate courses around biotechnology ventures integrates real-world science, business, career preparation and creative thinking for STEM student preparation.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"14 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Biopharma dives into tumor-seeking radioactive drugs","authors":"","doi":"10.1038/s41587-025-02681-1","DOIUrl":"https://doi.org/10.1038/s41587-025-02681-1","url":null,"abstract":"Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum damage to healthy tissues.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"30 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Engineering non-viral protein nanoparticles to deliver nucleic acids and proteins to cells","authors":"","doi":"10.1038/s41587-025-02665-1","DOIUrl":"https://doi.org/10.1038/s41587-025-02665-1","url":null,"abstract":"Protein materials are promising drug delivery vehicles, but their use for intracellular protein and nucleic acid cargo delivery has been limited. We have developed self-assembling elastin-like polypeptide (ELP)-based protein nanoparticles that are functionalized to enable complexation and intracellular delivery of biomacromolecular cargo, including gene editors in the form of mRNA, plasmid DNA and ribonucleoproteins.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"51 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144066958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reprogramming endogenous regulatory DNA to fine-tune gene expression","authors":"Iris Marchal","doi":"10.1038/s41587-025-02686-w","DOIUrl":"https://doi.org/10.1038/s41587-025-02686-w","url":null,"abstract":"<p>Regulatory DNA sequences orchestrate cell-type-specific gene expression by facilitating transcription factor binding, yet their precise effects and reprogrammability remain challenging to delineate. Now, in <i>Cell</i>, Martyn et al. develop a method called variant effects from flow-sorting experiments with CRISPR targeting screens (Variant-EFFECTS), which measures the quantitative effects of changes to regulatory DNA on gene expression in endogenous contexts without the need for genetic engineering of reporters.</p><p>Variant-EFFECTS uses pooled prime editing to introduce hundreds of noncoding edits to regulatory sequences in cells. The cells are then labeled with RNA FlowFISH or a fluorescent antibody targeted to a gene of interest, and sorted on the basis of levels of fluorescence. To demonstrate the usefulness of the method, the authors performed tiling mutagenesis screens targeting the promotor and/or enhancer regions for two genes involved in immune responses (<i>PPIF</i> and <i>IL2RA</i>) in THP-1 cells and Jurkat T cells. This revealed several motif instances with strong effects on gene-expression levels, including some missed by massively parallel reporter assays. Variant-EFFECTS can also dissect the context-specific effects of transcription factor motifs by inserting them across cell types. Moreover, the authors used Variant-EFFECTS data to benchmark deep-learning models that predict gene regulatory signals directly from DNA sequence, which revealed limitations to these models for predicting effect sizes of variants.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"27 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"People","authors":"","doi":"10.1038/s41587-025-02670-4","DOIUrl":"https://doi.org/10.1038/s41587-025-02670-4","url":null,"abstract":"Recent moves of note in and around the biotech and pharma industries.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"11 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144066957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Brazil’s low-cost CAR-Ts take on Global South","authors":"","doi":"10.1038/s41587-025-02691-z","DOIUrl":"https://doi.org/10.1038/s41587-025-02691-z","url":null,"abstract":"<p>Brazil is the first country in Latin America to produce its own cut-price chimeric antigen receptor (CAR)-T cell therapies. Now, Caring Cross, a US-based non-profit focused on making advanced therapies affordable, plans to expands Brazil’s model to Turkey and the Middle East.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"132 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144066966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A gut-derived peptide protects citrus trees from Huanglongbing","authors":"Iris Marchal","doi":"10.1038/s41587-025-02687-9","DOIUrl":"https://doi.org/10.1038/s41587-025-02687-9","url":null,"abstract":"<p>Huanglongbing is a devastating bacterial disease of citrus trees with no known cure. An emerging strategy to provide resistance to plant pathogens is disrupting genes that increase disease susceptibility. A paper in <i>Science</i> by Zhao et al. uses this approach in citrus trees, and identifies a regulatory circuit that can be modulated to alleviate Huanglongbing disease symptoms.</p><p>Huanglongbing can infect all citrus plants, and only some lineages naturally display tolerance or resistance. This prompted the authors to compare the transcriptional responses of different lineages upon infection. They found the E3 ubiquitin ligase <i>PUB21</i> to be highly upregulated in disease-sensitive plants, but not in disease-tolerant plants. Further analysis showed that PUB21 targets MYC2 — an immune protein that is important for jasmonate-mediated defense — for degradation. PUB21 and MYC2 form a regulatory circuit, in which MYC2 binds the <i>PUB21</i> promotor to induce PUB21 expression, thereby degrading MYC2. The authors found that the Huanglongbing pathogen targets this circuit by enhancing the PUB21–MYC2 interaction to suppress immune defense and promote infection.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"29 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144067049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"3D bioprinting innovation and the patentability hurdle","authors":"Pratap Devarapalli, Dianne Nicol, Jane Nielsen","doi":"10.1038/s41587-025-02661-5","DOIUrl":"https://doi.org/10.1038/s41587-025-02661-5","url":null,"abstract":"How are patent examiners in the United States, Europe and Australia interpreting and applying the patentability criteria to specific subject matter related to 3D bioprinting technologies?","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"1 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144066969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Feyisayo Eweje, Vanessa Ibrahim, Aram Shajii, Michelle L. Walsh, Kiran Ahmad, Assma Alrefai, Dominie Miyasato, Jessie R. Davis, Hyunok Ham, Kaicheng Li, Michael Roehrl, Carolyn A. Haller, David R. Liu, Jiaxuan Chen, Elliot L. Chaikof
{"title":"Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins","authors":"Feyisayo Eweje, Vanessa Ibrahim, Aram Shajii, Michelle L. Walsh, Kiran Ahmad, Assma Alrefai, Dominie Miyasato, Jessie R. Davis, Hyunok Ham, Kaicheng Li, Michael Roehrl, Carolyn A. Haller, David R. Liu, Jiaxuan Chen, Elliot L. Chaikof","doi":"10.1038/s41587-025-02664-2","DOIUrl":"https://doi.org/10.1038/s41587-025-02664-2","url":null,"abstract":"<p>Intracellular delivery of biomacromolecules is hampered by low efficiency and cytotoxicity. Here we report the development of elastin-based nanoparticles for therapeutic delivery (ENTER), a recombinant elastin-like polypeptide (ELP)-based delivery system for effective cytosolic delivery of biomacromolecules in vitro and in vivo. Through iterative design, we developed fourth-generation ELPs fused to cationic endosomal escape peptides (EEPs) that self-assemble into pH-responsive micellar nanoparticles and enable cytosolic entry of cargo following endocytic uptake. In silico screening of α-helical peptide libraries led to the discovery of an EEP (EEP13) with 48% improved protein delivery efficiency versus a benchmark peptide. Our lead ELP–EEP13 showed similar or superior performance compared to lipid-based transfection reagents in the delivery of mRNA-encoded, DNA-encoded and protein-form Cre recombinase and CRISPR gene editors as well as short interfering RNAs to multiple cell lines and primary cell types. Intranasal administration of ELP–EEP13 combined with Cre protein achieved efficient editing of lung epithelial cells in reporter mice.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"125 1","pages":""},"PeriodicalIF":46.9,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143979368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}